Dr Richard Rutter
Chief Scientific Officer
Richard has worked in the pharma industry for over 15 years, joining Auspherix from GlaxoSmithKline where he was Head of Biology at its Neuroscience R&D Centre in Singapore. His experience spans from novel target identification through to the progression of compounds into clinical studies and he has a track record of establishing successful external partnerships. Previously, Richard was a Senior Research Biologist at Merck Sharpe and Dohme in the UK. He has a PhD in Molecular Neuroscience from the University of London.
